Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Voriconazole therapeutic drug monitoring including analysis of CYP2C19 phenotype in immunocompromised pediatric patients with invasive fungal infections.

  • Authors : Resztak M; Department of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, Poznań, Poland. .; Zalewska P

Subjects: Voriconazole*/Voriconazole*/Voriconazole*/pharmacokinetics ; Voriconazole*/Voriconazole*/Voriconazole*/therapeutic use ; Voriconazole*/Voriconazole*/Voriconazole*/administration & dosage

  • Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2024 Nov; Vol. 80 (11), pp. 1829-1840. Date of Electronic Publication: 2024 Sep 06.Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041

Record details

×
Academic Journal

Clinical non-effectiveness of clopidogrel use for peripheral artery disease in patients with CYP2C19 polymorphisms: a systematic review.

  • Authors : Huang S; Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, USA.; Yang S

Subjects: Clopidogrel*/Clopidogrel*/Clopidogrel*/adverse effects ; Clopidogrel*/Clopidogrel*/Clopidogrel*/therapeutic use ; Cytochrome P-450 CYP2C19*/Cytochrome P-450 CYP2C19*/Cytochrome P-450 CYP2C19*/genetics

  • Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2022 Aug; Vol. 78 (8), pp. 1217-1225. Date of Electronic Publication: 2022 Jun 03.Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041

Record details

×
Academic Journal

Evaluation of CYP2C19 activity using microdosed oral omeprazole in humans.

  • Authors : Elbe A; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Foerster KI

Subjects: Cytochrome P-450 CYP2C19*/Cytochrome P-450 CYP2C19*/Cytochrome P-450 CYP2C19*/genetics ; Cytochrome P-450 CYP2C19*/Cytochrome P-450 CYP2C19*/Cytochrome P-450 CYP2C19*/metabolism ; Omeprazole*/Omeprazole*/Omeprazole*/administration & dosage

  • Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2022 Jun; Vol. 78 (6), pp. 975-987. Date of Electronic Publication: 2022 Mar 03.Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041

Record details

×
Academic Journal

Tailored P2Y 12 inhibitor treatment in patients undergoing non-urgent PCI-the POPular Risk Score study.

  • Authors : Janssen PWA; Department of Cardiology, St Antonius Hospital, P/O Box 2500, 3432 EM, Nieuwegein, The Netherlands. .; St Antonius Centre for Platelet Function Research, St Antonius Hospital, Nieuwegein, The Netherlands. .

Subjects: Percutaneous Coronary Intervention*; Clopidogrel/Clopidogrel/Clopidogrel/*therapeutic use ; Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/*genetics

  • Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2019 Sep; Vol. 75 (9), pp. 1201-1210. Date of Electronic Publication: 2019 Jun 14.Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041

Record details

×
Academic Journal

Clopidogrel utilization in patients with coronary artery disease and diabetes mellitus: should we determine CYP2C19*2 genotype?

  • Authors : Chouchene S; Hematology Department, Fattouma Bourguiba University Hospital, TN 5000, Monastir, Tunisia. .; Dabboubi R

Subjects: Clopidogrel/Clopidogrel/Clopidogrel/*therapeutic use ; Coronary Artery Disease/Coronary Artery Disease/Coronary Artery Disease/*drug therapy ; Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/*genetics

  • Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2018 Dec; Vol. 74 (12), pp. 1567-1574. Date of Electronic Publication: 2018 Aug 03.Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041

Record details

×
Academic Journal

Utility of a pharmacogenetic-driven algorithm in guiding dual antiplatelet therapy for patients undergoing coronary drug-eluting stent implantation in China.

  • Authors : Lyu SQ; Emergency and Critical Care Center, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 167 Beilishi Road, Xicheng District, Beijing, People's Republic of China.; Zhu J

Subjects: Drug-Eluting Stents*; Asian People/Asian People/Asian People/*genetics ; Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/*genetics

  • Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2022 Feb; Vol. 78 (2), pp. 215-225. Date of Electronic Publication: 2021 Oct 12.Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041

Record details

×
Academic Journal

Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.

  • Authors : Lin J; Department of Neurology, Third Affiliated Hospital of Wenzhou Medical University, Ruian, 325200, Zhejiang, China.; Han Z

Subjects: Pharmacogenomic Variants*; Aspirin/Aspirin/Aspirin/*therapeutic use ; Brain Ischemia/Brain Ischemia/Brain Ischemia/*drug therapy

  • Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2018 Sep; Vol. 74 (9), pp. 1131-1140. Date of Electronic Publication: 2018 May 26.Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041

Record details

×
Academic Journal

Effect of CYP2C19, UGT1A8, and UGT2B7 on valproic acid clearance in children with epilepsy: a population pharmacokinetic model.

  • Authors : Mei S; Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, 6 Tiantan Xili, Dongcheng District, Beijing, 100050, People's Republic of China.; Department of Clinical Pharmacology, College of Pharmaceutical Sciences, Capital Medical University, Beijing, 100045, People's Republic of China.

Subjects: Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/*genetics ; Epilepsy/Epilepsy/Epilepsy/*blood ; Glucuronosyltransferase/Glucuronosyltransferase/Glucuronosyltransferase/*genetics

  • Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2018 Aug; Vol. 74 (8), pp. 1029-1036. Date of Electronic Publication: 2018 Apr 17.Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041

Record details

×
Academic Journal

Effect of cytochrome P450 2C19 polymorphism on adverse cardiovascular events after drug-eluting stent implantation in a large Hakka population with acute coronary syndrome receiving clopidogrel in southern China.

  • Authors : Zhong Z; Center for Cardiovascular Diseases, Meizhou People's Hospital (Huangtang Hospital), Meizhou Hospital Affiliated to Sun Yat-sen University, Meizhou, 514031, People's Republic of China.; Hou J

Subjects: Drug-Eluting Stents* ; Pharmacogenomic Variants* ; Polymorphism, Genetic*

  • Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2018 Apr; Vol. 74 (4), pp. 423-431. Date of Electronic Publication: 2017 Dec 14.Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041

Record details

×
Academic Journal

Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel.

  • Authors : Novkovic M; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, P.O. Box 23, 11010, Belgrade, Serbia.; Matic D

Subjects: Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/adverse effects ; Pharmacogenomic Variants* ; Polymorphism, Single Nucleotide*

  • Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2018 Apr; Vol. 74 (4), pp. 443-451. Date of Electronic Publication: 2017 Dec 19.Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041

Record details

×
  • 1-10 of  167 results for ""CYTOCHROME P-450 CYP2C19""